Direct answer (40-60 words)
Most surgical and anesthesia guidelines recommend pausing Zepbound for 1 week before surgery (longer for higher-dose patients) due to delayed gastric emptying and aspiration risk. After surgery, restart only when normal eating, drinking, and bowel function return, typically 1 to 2 weeks for routine procedures, longer for major abdominal surgery.
Table of contents
- The 30-second answer
- Why Zepbound matters around surgery: the aspiration mechanism
- The ASA 2023 guidance and what it actually says
- How long to pause before surgery: a practical table
- The risk if you forget to pause
- The pre-op fasting question
- When you can restart Zepbound after surgery
- Restarting at the right dose, not where you left off
- Special cases: bariatric, abdominal, and elective cosmetic surgery
- What to tell your surgical team
- FAQ
- Footer disclaimers
Why Zepbound matters around surgery: the aspiration mechanism
Zepbound's active ingredient, tirzepatide, slows gastric emptying. The normal stomach empties about half its contents in roughly 90 minutes. On tirzepatide at maintenance dose, that half-emptying time can extend to 3 to 4 hours, sometimes longer after a high-fat meal. This is the same mechanism that makes you feel full faster and stay full longer; it's what drives the weight-loss effect.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →In daily life, slow gastric emptying is mostly a nuisance (early satiety, occasional reflux). Around general anesthesia, it becomes a real safety concern.
When a patient is induced for general anesthesia, the protective airway reflexes that normally keep stomach contents out of the lungs are suppressed. If food or fluid is still in the stomach when induction happens, that material can passively reflux up the esophagus and be inhaled into the lungs. This is called pulmonary aspiration. In its severe form, it causes aspiration pneumonia, chemical pneumonitis, and rarely death.
The standard pre-op fasting guidance (no solids 8 hours before, no clear liquids 2 hours before) was developed assuming a normally functioning stomach. On a GLP-1 receptor agonist, that assumption no longer holds. Several case reports beginning in 2022 documented patients arriving for surgery with substantial residual stomach content despite following standard fasting rules. A 2023 paper in the Canadian Journal of Anesthesia (Klein et al.) found endoscopic evidence of solid food in the stomach of GLP-1 patients who had fasted for 8+ hours.
This is the reason guidance changed.
The ASA 2023 guidance and what it actually says
The American Society of Anesthesiologists released formal guidance in June 2023 specifically addressing GLP-1 medications and elective surgery. The key elements:
- For elective procedures, hold the medication based on dosing schedule. For weekly GLP-1 medications like tirzepatide (Zepbound, Mounjaro) and semaglutide (Ozempic, Wegovy), hold for 1 week before the procedure. For daily medications like liraglutide (Saxenda, Victoza), hold the day of the procedure.
- For higher-dose patients, consider holding longer. Some institutions have moved to 10 to 14 days for patients on the highest doses (Zepbound 12.5 or 15 mg, Wegovy 2.4 mg) based on the longer time-to-steady-state.
- For urgent or emergent surgery, treat the patient as having a full stomach. This means rapid-sequence induction or other airway-protective techniques regardless of fasting time.
- Consider gastric ultrasound at point of care. Some anesthesia teams now scan the stomach directly with bedside ultrasound before induction in patients who have been on GLP-1s recently.
The guidance is described as cautious because the published aspiration rates on GLP-1 medications are low in absolute terms. A 2024 retrospective study in JAMA Surgery (Yeo et al.) looked at over 12,000 patients and found aspiration events in roughly 0.3% of GLP-1 patients vs 0.1% of matched controls. Three-fold relative risk, but small absolute numbers.
The clinical reasoning: aspiration is rare but devastating when it happens, and the cost of a 1-week medication pause is minimal. Asymmetric risk-reward favors pausing.
How long to pause before surgery: a practical table
Different combinations of dose, surgery type, and clinical context get different recommendations. The table below reflects what most major centers are now doing as of late 2025.
| Scenario | Pre-op pause |
|---|---|
| Zepbound 2.5 mg or 5 mg, routine elective surgery (general anesthesia) | 7 days |
| Zepbound 7.5 mg or 10 mg, routine elective surgery | 7 to 10 days |
| Zepbound 12.5 mg or 15 mg, routine elective surgery | 10 to 14 days |
| Any dose, gastrointestinal or bariatric surgery | 14 days minimum |
| Any dose, urgent/emergent surgery | No pause; treat as full stomach |
| Any dose, procedure with sedation only (no general anesthesia) | 3 to 7 days, per anesthesia team |
| Any dose, local anesthesia only (no sedation) | Often no pause needed; confirm with team |
| Compounded tirzepatide (any concentration) | Same as comparable Zepbound dose |
These are guidelines, not rules. The final decision belongs to the anesthesia team performing the procedure. They factor in your full medication list, comorbidities, and the specifics of the planned anesthesia.
A practical note: if your surgery date moves up unexpectedly and you've taken a dose within the past 7 days, tell the surgical team immediately. Don't try to power through. They'll either reschedule or modify the anesthesia plan.
The risk if you forget to pause
If you take a Zepbound dose within the recommended pre-op window and don't tell the surgical team, the most likely outcomes are:
- The team discovers it during pre-op screening and reschedules the procedure
- The team proceeds with rapid-sequence induction (treating you as a full stomach)
- The team performs gastric ultrasound and decides based on what they see
- In rare cases, the procedure proceeds with standard induction and aspiration occurs
The first three are inconvenient but safe. The fourth is what the guidance is designed to prevent. The published case reports of aspiration events almost universally involve patients who didn't disclose their GLP-1 use.
If you've already injected within the window, the right move is always to disclose. The team would much rather adjust the plan than discover the problem mid-procedure.
The pre-op fasting question
Standard pre-op fasting on Zepbound is more conservative than for non-GLP-1 patients. The current consensus, while still evolving, is:
- No solid food for at least 12 hours before surgery (vs the standard 8)
- No clear liquids for 4 hours before (vs the standard 2)
- Light fluids encouraged up to 4 hours out to support hydration without leaving stomach contents
Some centers extend the no-solids window to 16 to 24 hours for patients still in the early days of their pre-op pause window. The reasoning is that residual delayed emptying can persist for several days after the last dose.
Hydration is genuinely important here. The combination of GLP-1-driven low fluid intake during normal life, plus a longer fasting window, plus surgical stress, can produce real dehydration. Most anesthesiologists prefer slightly over-hydrated to slightly under-hydrated, especially for outpatient procedures.
When you can restart Zepbound after surgery
The pause-after restart timing depends on three things: how well your gut function has returned, what type of procedure you had, and whether complications occurred.
General principles for restart:
- Tolerating a full diet without nausea or vomiting for at least 48 hours
- Normal bowel function has returned (passing gas, having bowel movements)
- No active wound infection or impaired healing
- Stable hydration without IV fluid support
- Surgical team has cleared resumption of pre-op medications
Typical restart windows by surgery type:
| Surgery type | Earliest reasonable restart |
|---|---|
| Outpatient procedure with sedation only | 3 to 5 days |
| Routine outpatient general anesthesia (knee scope, oral surgery) | 5 to 7 days |
| Inpatient surgery, no GI involvement (orthopedic, cardiac) | 7 to 14 days |
| Major abdominal surgery (non-bariatric) | 4 to 6 weeks |
| Bariatric surgery (gastric bypass, sleeve) | Per surgical team; often 6+ weeks if at all |
| Cesarean section or vaginal delivery | Per OB and prescribing provider; usually 4 to 8 weeks |
For most routine surgeries, the practical question is whether you're eating normally and whether your incision is healing well. If both yes, restart is usually fine after a clearance call with your prescribing provider.
Restarting at the right dose, not where you left off
The mistake most patients make on restart is trying to pick up where they left off. If you were on Zepbound 10 mg before surgery and you've been off for 3 weeks, restarting at 10 mg can produce nausea and vomiting that mimic surgical complications.
The general rule:
- Pause less than 2 weeks: restart at the same dose
- Pause 2 to 4 weeks: consider stepping down one dose level (e.g., 10 mg back to 7.5 mg) for the first few injections
- Pause more than 4 weeks: restart at the lowest dose (2.5 mg) and re-titrate, or at most 5 mg if you previously tolerated maintenance well
The reason is that GLP-1 receptor sensitivity adjusts during the off period. The same dose you tolerated for months can feel like a starter dose after a 4-week break. Re-titrating slowly avoids the reflux, nausea, and underfueling that can derail an otherwise normal surgical recovery.
This is similar to the titration logic that applies to undereating on Zepbound: the medication is most likely to cause problems when intake is already low, which is precisely the post-surgical state.
Special cases: bariatric, abdominal, and elective cosmetic surgery
Bariatric surgery: the calculus is different. Patients undergoing gastric bypass or sleeve gastrectomy are typically having their weight-loss tools restructured by the procedure itself. Most bariatric surgeons recommend stopping GLP-1 medications well in advance (4 to 8 weeks pre-op) and not resuming for at least 6 weeks post-op, sometimes longer. Whether to restart at all is a separate conversation with the bariatric team.
Major abdominal surgery (colectomy, hysterectomy, etc.): the post-op ileus (delayed gut function after surgery) interacts unpredictably with tirzepatide's slowing effect. Most surgical teams recommend a longer post-op pause (4 to 6 weeks) to allow complete return of gut function before re-introducing a medication that further slows it.
Elective cosmetic surgery (liposuction, breast surgery, abdominoplasty): these procedures often involve significant body contouring that depends on stable weight. Many cosmetic surgeons want patients at goal weight and stable for 3 to 6 months pre-op, which usually means continuing Zepbound until close to the procedure, then pausing per anesthesia guidance, then resuming when healing allows.
Endoscopy and colonoscopy: these are technically procedures with sedation, not general anesthesia, but the visualization quality depends on an empty stomach. Most GI teams now recommend a 1-week pause before upper endoscopy and a slightly less strict approach for routine colonoscopy (where the bowel prep is the main factor).
What to tell your surgical team
Bring a list to your pre-op appointment. The information that matters:
- Medication name (Zepbound, Wegovy, Mounjaro, compounded tirzepatide, compounded semaglutide)
- Dose in mg (not just "the highest one" or "the lowest one")
- Date of last injection
- How long you've been on this dose
- Any GI side effects you've had (nausea, vomiting, reflux, constipation)
- Other relevant medications (diabetes medications especially)
Don't assume they've already pulled this from your medical record. GLP-1 medications are sometimes tracked under different names depending on whether you're on a brand-name prescription, compounded version, or telehealth program. Telehealth-prescribed compounded medications often don't show up in hospital systems automatically.
If you're on compounded tirzepatide through a telehealth platform, bring the prescription label or the original packaging if you have it. The concentration matters; "1 mL twice a week" tells the anesthesia team almost nothing without the mg/mL concentration.
FAQ
How long do I have to stop Zepbound before surgery?
Most institutions follow the ASA 2023 guidance: at least 7 days for weekly GLP-1 medications including Zepbound, longer (10 to 14 days) for higher-dose patients or GI-related surgery. The final call is your anesthesia team's.
What happens if I take Zepbound the week of my surgery?
Tell the surgical team immediately. They'll likely either reschedule or modify the anesthesia plan to treat you as a full-stomach patient (rapid-sequence induction, possibly gastric ultrasound). Don't try to hide it.
When can I restart Zepbound after surgery?
When normal eating, drinking, and bowel function have returned and your prescribing provider clears it. For routine outpatient surgery, usually 5 to 7 days. For major abdominal surgery, often 4 to 6 weeks.
Do I need to restart at a lower dose after surgery?
If your pause was longer than 2 weeks, yes. Pauses of 2 to 4 weeks usually mean stepping down one dose level. Pauses longer than 4 weeks usually mean restarting at 2.5 or 5 mg and re-titrating.
Will I gain weight back during a 2-week pause?
Most patients see a small amount of regain during a short pause (2 to 4 lb is typical, mostly water and appetite-driven food intake). This usually comes off within a few weeks of restart and isn't a long-term setback.
Can I take Zepbound the morning of an outpatient procedure with only sedation?
Probably not, but ask the team. Sedation suppresses airway reflexes less completely than general anesthesia, but the aspiration risk on GLP-1 medications still exists. Most centers want at least 3 to 7 days of pause even for sedation-only procedures.
What if my surgery is urgent and I can't pause?
The anesthesia team will treat you as a full-stomach patient and use rapid-sequence induction or other airway-protective techniques. The risk is higher than for an elective procedure with proper pause, but the techniques are well-established. Disclosure is what matters.
Does the same guidance apply to compounded tirzepatide?
Yes. Compounded tirzepatide contains the same active molecule and acts through the same mechanism. The pause-before guidance is the same as for brand-name Zepbound at equivalent doses. Bring the concentration of your specific formulation when you talk to the surgical team.
Will my surgery be canceled if I forgot to pause Zepbound?
Possibly. Many centers cancel and reschedule rather than proceed with elevated aspiration risk. Some proceed with modified technique. The decision is the anesthesia team's, and it's better made with full information than mid-procedure.
Can I take Zepbound the week before a colonoscopy?
Most GI teams want a pause for upper endoscopy. For colonoscopy, where the bowel prep itself empties the GI tract, the answer is more flexible. Ask your gastroenterologist directly.
How does Zepbound affect anesthesia recovery?
Most patients recover normally. The medication can prolong post-op nausea (because it slows gastric emptying and increases susceptibility to anesthesia-induced nausea) and can delay return of normal bowel function. Both are usually manageable.
Does pausing Zepbound affect my blood sugar if I have diabetes?
Yes, it can. If you're using Zepbound for type 2 diabetes (or have type 2 diabetes plus weight management), your blood sugar will likely run higher during the pause. Most providers prescribe a short-acting alternative (basal insulin, sulfonylurea, or DPP-4 inhibitor) to bridge the gap, and discontinue it when Zepbound is restarted.
Author / review note
Reviewed by the FormBlends Medical Team. References include the American Society of Anesthesiologists 2023 consensus statement on perioperative management of GLP-1 receptor agonists, Klein et al., Canadian Journal of Anesthesia, 2023 (residual gastric content with GLP-1s), Yeo et al., JAMA Surgery, 2024 (aspiration risk retrospective), and the ASGE 2023 statement on GLP-1 medications and endoscopy.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Wegovy, Ozempic, Saxenda, and Victoza are registered trademarks of Novo Nordisk. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →